These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10712030)

  • 1. Managing patients with lung cancer. Common international guidelines must be developed.
    Ardizzoni A; Grossi F; Salvati F; Silvano G; Santi L
    BMJ; 2000 Feb; 320(7231):380. PubMed ID: 10712030
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing patients with lung cancer. Guidelines must help bring us in line with European standards.
    O'Brien ME; Cullen M
    BMJ; 2000 Jun; 320(7249):1604-5. PubMed ID: 10896440
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung cancer adjuvant therapy.
    Horn L; Sandler A
    Cancer J; 2007; 13(3):210-6. PubMed ID: 17620772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung cancer].
    Tsuboi M; Kato H
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1538-42. PubMed ID: 17940368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines update: non-small cell lung cancer.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2005 Mar; 3(2):xxix-xxx. PubMed ID: 19817021
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer management concerns in New Zealand.
    Garrett J
    N Z Med J; 2004 Jun; 117(1196):U929. PubMed ID: 15280933
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of ASCO 2003 to our clinical practice in NSCLC].
    Pérol M
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 2):S44-9. PubMed ID: 14707916
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012.
    Gandara DR; Mack PC; Li T; Lara PN; Herbst RS
    Clin Lung Cancer; 2009 Nov; 10(6):392-4. PubMed ID: 19900855
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improved prognosis in non small cell lung cancer--myth or reality?].
    Milleron B; Lavolé A; Gounant V
    Rev Mal Respir; 2005 Dec; 22(6 Pt 2):8S137-42. PubMed ID: 16340850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.